as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet reactivity. Earlier studies also seem to indicate that reloading patients already on maintenance ...

Participants, all event-free after 6 to 18 months following PCI, were randomized 1:1 to receive either clopidogrel (75 mg daily) or aspirin (100 mg daily). Subgroups were classified based on HBR ...

plus extended-release dipyridamole (200 mg) given twice daily, or clopidogrel (75 mg) given once daily. The study was sponsored by the maker of the aspirin/dipyridamole combination (Aggrenox).

The body converts prasugrel to its active form considerably faster than it does clopidogrel. Indeed, the approved, 300-mg dose of clopidogrel takes hours to reach full strength—a potentially ...

Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

90 mg twice daily thereafter) or clopidogrel 300–600 mg loading dose, 75 mg daily thereafter). During the 12-month follow-up period, the primary end point of death from cardiovascular causes ...